4 参考文献
1. Ramer MS, Harper GP, BradbuV EJ. Progress in spinal cord research - a refined strategy for the International Spinal Research Research Trust[J].Spinal Cord, 2000, 38( 8) : 449- 472.
2. Baptiste DC, Fehlinqs MG. Pharmacological approaches to repair the injured spinal cord[J].J Neurotrauma, 2006, 23( 3- 4) :318- 334.
3. Juul S. Erythropoietin in the central nervous system, and itsuse to prevent hypoxic- ischemin brain damage[J].Acta Paediatr,2002, 91( 438) : 36- 42.
4. Doggrell SA.A neuroprotective derivative of erythropoietin that is not erythropoietic [J].Expert Opin Investig Drugs, 2004, 13( 11) : 1517- 1519.
5. Leist M, Ghezzi P, Grasso G, et al.Derivatives of erythropoietin that are tissue protective but not erythropoietic [J].Science,2004, 305( 5681) : 239- 242.
6. Hasselbatt M, Ehrenreich H, Siren AL.The brain erythropoietin system and its potential for therapeutic exploitation in brain disease[J].L Neurosurg Anesthesiol, 2006, 18( 2) : 132- 138.
7. Sirén AL, Knerlich F, Poser W, et al. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain [J].Acta Neuropathol, 2001, 101( 3) : 271- 276.
8. Grasso G, Sfacteria A, Erbayraktars, et al.Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietin derivative [J].JNeurosurg Spine, 2006, 4( 4) : 310- 318.
9. Sela S, Shurtz SR, Sharon R, et al. The polymorphonuclear leukocytea new target for erythropoietin [J].Nephron, 2001, 88( 3) : 205- 210.
10. Savino C, Pedotti R, Baggi F, et al. Delayed administration of erythropoietin and its non - erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis[J].J Neuroimmunol,2006, 172( 1- 2) : 27- 37.
11. Gorio A, Madaschi L, Di Stefano B, et al. Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury [J].Proc Natl Acad Sci USA, 2005,102( 45) : 16379- 16384.
12. Okutan O, Solaroqlu I, Beskonakli E, et al. Recombinant human erythropoietin decreases myeloperoxidase and caspase- 3activity and improves early functional results after spinal cord injury in rats[J].J Clin Neurosci, 2007, 14( 4) : 364- 368.
13. 吴天顺, 任先军, 滕晓华, 等.促红细胞生成素对脊髓缺血再灌注损伤保护作用及其机理的实验研究[J].中国矫形外科杂志,2005, 13( 9) : 677- 679.
14. Sirén AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress[J].Proc Natl Acad Sci USA, 2001, 98( 7) : 4044- 4049.
15. Morishita E, Masuda S, Nagao M, et al.Erythropoietin receptor is expression in rat hippocampal and cerebral cortical neurons,and erythropoietin prevents in vitro glutamate - induced neuronal death[J].Neroscience, 1997, 76( 1) : 105- 116.
16. Celik M, Gokmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury [J].Natl Acad Sci US-A, 2002, 99( 4) : 2258- 2263.
17. Morishita E, Masuda S, Nagao M, et al.Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons,and erythropoietin prevents in vitro glutamate - induced neuronal death[J].Neuroscience, 1997, 76( 1) : 105- 116.
18. 王金光, 郑启新, 郭晓东.重组人红细胞生成素与β- 七叶皂甙钠治疗大鼠脊髓损伤的实验研究[J]. 中国脊柱脊髓杂志,2003, 13( 11) : 674- 677.
19. Anagnostou A, Liu Z, Steiner M, et al. Erythropoietin receptor mRNA expression in human endothelial cells [J].Natl AcadSci USA, 1994, 91( 9) : 3974- 3978.
20. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro [J].Kindey Int,1995, 47( 3) : 740- 745.
21. 吴岩, 陈友琴, 龚丽, 等.重组人促红细胞生成素抑制内皮细胞凋亡的实验研究[J].中国医学物理学杂志, 2001, 18( 3) : 185-186.
22. Marti HH, Bernaudin M, Petit E, et al. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia[J].News Physiol Sci, 2000, 15: 225- 229.
23. Bernaudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice[J].Cereb Blood Flow Metab, 1999, 19( 6) : 643- 651.
24. Lee SM, Nguyen TH, Park MH, et al. EPO receptor- mediated ERK kinase and NF - kappaB activation in erythropoietin -promoted differentiation of astrocytes [J].Biochem BiophysCommun, 2004, 320( 4) : 1087- 1095.
25. Sonmez A, Kabakci B, Vardar E, et al. Erythropoietin attenuates neuronal injury and potentiates the expression of pCREB in anterior horn after transient spinal cord ischemia in rats[J].Surg Neurol, 2007, 68( 3) : 297- 303.
26. Kawakami M, Sekiguchi M, Sato K, et al. Erythropoietin receptor- mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia [J].BiolChem, 2001, 276( 42) : 39469- 39475.
27. Parganas E,Wang D, Stravopodis D, et al.Jak2 is essential for signaling through a variety of cytokine receptors [J].Cell,1998, 93( 3) : 385- 395.
28. Rtner M, Nielsch U, Mayr LM, et al. A new high affinity binding site for suppressor of cytokine signaling- 3 on the erythropoietin receptor [J].Eur Biochem, 2002, 269 ( 10) : 2516-2526.
来源:中国脊柱脊髓杂志 作者:周传利 陈晓亮 郑修军
精彩推荐
免责声明:本文仅代表作者个人观点,与本网无关。转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责。对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不作任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
常见药品专题
常见疾病专题
药品
疾病
药企
药店
关键词: